|
|
|
Financials-Aurobindo Pharma Limited| Sector: Bulk Drugs | | BSE:524804 | NSE:AUROPHARMA | Bloomberg:ARBP@IN | Reuters:ARBN.BO | | Market Lot: 1 | Face Value: 1 | ISIN Demat: INE406A01037 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Dec-2020(3) |
31-Dec-2019(3) |
% Change |
| Sales of Products/Services |
37108.60 |
33456.70 |
10.92 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
1649.70 |
168.80 |
877.31 |
| Total Income |
38758.30 |
33625.50 |
15.26 |
| Total Expenses |
-28635.80 |
-28132.50 |
1.79 |
| OPBDIT |
67394.10 |
61758.00 |
9.13 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-1206.30 |
-28132.50 |
-95.71 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-2717.40 |
-1302.30 |
108.66 |
| After Tax Profit |
7405.10 |
4190.70 |
76.70 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-07(12) |
|
31-Mar-06(12) |
|
31-Mar-05(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
18741.00 |
98.87 |
13907.70 |
99.17 |
10803.50 |
99.17 |
| Operating Income (OI) |
18955.50 |
100.00 |
14023.60 |
100.00 |
10893.60 |
100.00 |
| OPBDIT |
3000.60 |
15.83 |
1901.20 |
13.56 |
1323.60 |
12.15 |
| OPBDT |
2414.70 |
12.74 |
1252.70 |
8.93 |
789.20 |
7.24 |
| OPBT |
1696.20 |
8.95 |
741.50 |
5.29 |
384.30 |
3.53 |
| Non-Operating Income |
615.40 |
3.25 |
187.50 |
1.34 |
44.90 |
0.41 |
| Extraordinary/Prior Period |
18.20 |
0.10 |
-223.20 |
-1.59 |
-38.30 |
-0.35 |
| Tax |
39.00 |
0.21 |
12.00 |
0.09 |
40.10 |
0.37 |
| Profit after tax(PAT) |
2290.80 |
12.09 |
693.80 |
4.95 |
350.80 |
3.22 |
| Cash Profit |
3009.30 |
15.88 |
1205.00 |
8.59 |
755.70 |
6.94 |
| Dividend-Equity |
133.40 |
0.70 |
81.20 |
0.58 |
25.40 |
0.23 |
|
| As on |
31-Mar-07 |
|
31-Mar-06 |
|
31-Mar-05 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
9424.60 |
28.24 |
8769.00 |
35.55 |
7297.40 |
38.03 |
| Net Block |
7106.50 |
21.30 |
6816.80 |
27.64 |
5780.50 |
30.13 |
| Capital WIP |
1831.40 |
5.49 |
1454.50 |
5.90 |
1765.00 |
9.20 |
| Investments |
2026.10 |
6.07 |
1740.40 |
7.06 |
1511.50 |
7.88 |
| Inventory |
5472.80 |
16.40 |
3834.40 |
15.55 |
3235.80 |
16.86 |
| Receivables |
6244.10 |
18.71 |
5690.00 |
23.07 |
4413.80 |
23.00 |
| Other Current Assets |
10690.10 |
32.03 |
5129.60 |
20.80 |
2480.30 |
12.93 |
| Balance Sheet Total(BT) |
33371.00 |
100.00 |
24665.70 |
100.00 |
19186.90 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
266.70 |
0.80 |
266.30 |
1.08 |
253.90 |
1.32 |
| Reserves |
9008.00 |
26.99 |
8420.40 |
34.14 |
7814.70 |
40.73 |
| Total Debt |
19763.40 |
59.22 |
12052.20 |
48.86 |
8291.20 |
43.21 |
| Creditors and Acceptances |
2840.80 |
8.51 |
2679.30 |
10.86 |
1835.90 |
9.57 |
| Other current liab/prov. |
1492.10 |
4.47 |
1247.50 |
5.06 |
991.20 |
5.17 |
| Balance Sheet Total(BT) |
33371.00 |
100.00 |
24665.70 |
100.00 |
19186.90 |
100.00 |
|
| As on |
31-Mar-07 |
31-Mar-06 |
31-Mar-05 |
| OPBIT/Prod.cap.empl.(%) |
9.06 |
7.92 |
7.02 |
| PBIT/Cap. Employed (%) |
10.72 |
7.02 |
6.34 |
| PAT/Networth (%) |
24.70 |
7.99 |
4.35 |
| Tax/PBT (%) |
1.67 |
1.70 |
10.26 |
| Total Debt/Networth (x) |
2.13 |
1.39 |
1.03 |
| Long Term Debt/Networth (x) |
1.87 |
0.76 |
0.45 |
| PBDIT/Finance Charges (x) |
6.20 |
2.88 |
2.49 |
| Current Ratio (x) |
5.17 |
3.73 |
3.58 |
| RM Inventory (days consumption) |
140.81 |
125.94 |
148.70 |
| FG inventory (days cost of sales) |
9.57 |
6.90 |
9.15 |
| Receivables (days gross sales) |
115.12 |
141.07 |
138.98 |
| Creditors (days cost of sales) |
64.99 |
80.67 |
70.02 |
| Op. curr. assets (days OI) |
362.00 |
326.00 |
294.00 |
|
|
Financials